| Net loss | -9.8M |
| Depreciation and amortization | 2.26M |
| Provision for doubtful accounts | |
| Impairment of property, plant and equipment | |
| Loss on disposal of property, plant and equipment | |
| Share-based compensation | 841K |
| Warrant liability expense | -314K |
| Deferred tax benefit | 0 |
| Reorganization expenses | |
| Loss on equity method investments | |
| Settlement with former officer | |
| Gain on extinguishment of debt | 0 |
| Other | 98K |
| Accounts receivable | -377K |
| Inventories | 146K |
| Other current assets | 206K |
| Accounts payable and accrued expenses | 2.95M |
| Pre-petition liabilities | |
| Net cash used in operating activities, before reorganization items | |
| Reorganization expenses | |
| Change in accounts payable for reorganization items | |
| Net cash used for reorganization items | |
| Net cash used in operating activities | |
| Receipts on note receivable | |
| Purchases of property, plant and equipment | -460K |
| Restricted cash | 1.92M |
| Proceeds from sale of property, plant and equipment | |
| Acquisition of additional interests in Rice Science and Rice Rx | |
| Other | |
| Net cash provided by (used in) investing activities | |
| Proceeds from sale of membership interests in Nutra SA, net of costs | 200K |
| Payments of debt, net of proceeds | |
| Proceeds from issuance of warrants and note conversion feature | 300K |
| Net cash provided by (used) in financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | -182K |
| Net change in cash and cash equivalents | 1.13M |
| Cash and cash equivalents, beginning of period | 1.07M |
| Cash and cash equivalents, end of period | 2.2M |
| Cash paid for interest | 1.32M |
| Cash paid for taxes | 20K |